Clinical trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer
NCT02635009
Study timeline
Study start (actual)2015-12-22Date precision: day
Registry last updated2026-07-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Limited Stage Small Cell Lung Carcinomaunresolved
Interventions
Sponsors & collaborators
NRG Oncologylead sponsor
National Cancer Institute (NCI)collaborator
Radiation Therapy Oncology Groupcollaborator
Mapped research locations
AtlantaGeorgia, United States5PhiladelphiaPennsylvania, United States4BaltimoreMaryland, United States4St LouisMissouri, United States4New YorkNew York, United States3ChicagoIllinois, United States3ClevelandOhio, United States3CharlotteNorth Carolina, United States3MilwaukeeWisconsin, United States3Kansas CityMissouri, United States3PeoriaIllinois, United States3Los AngelesCalifornia, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02635009 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.